The CXCL9/10/11-CXCR3 axis as a predictor of COVID-19 progression: a prospective, case-control study.

Çelik, Neslihan; Çelik, Onur; Laloglu, Esra; Özkaya, Alev

Çelik, Neslihan; Çelik, Onur; Laloglu, Esra; Özkaya, Alev.

Afiliação

Çelik N; Health Sciences University, Erzurum Regional Education and Research Hospital, Department of Infection Diseases and Clinical Microbiology, Erzurum, Turkey.
Çelik O; Health Sciences University, Erzurum Regional Education and Research Hospital, Department of Chest Diseases, Erzurum, Turkey.
Laloglu E; Ataturk University School of Medicine, Department of Biochemistry, Erzurum, Turkey.
Özkaya A; Health Sciences University, Erzurum Regional Education and Research Hospital, Department of Biochemistry, Erzurum, Turkey.

Rev Soc Bras Med Trop ; 56: e01282023, 2023.

Article em En | MEDLINE | ID: mdl-37493737

Assuntos

COVID-19; Quimiocina CXCL10; Humanos; Quimiocina CXCL10/metabolismo; Estudos de Casos e Controles; Estudos Prospectivos; COVID-19/diagnóstico; SARS-CoV-2; Receptores CXCR3/metabolismo; Quimiocina CXCL9

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Assunto principal: Quimiocina CXCL10 / COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Rev Soc Bras Med Trop Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google